“This opens up the Chinese market for us in relation to our flavour enhancer, which works particularly well with sweeteners such as stevia,” he continued.
Following on from last week’s approval for stevia in Europe, Dikansky, said there are now massive opportunities for Talin, which is produced in the company’s UK facility, stressing that fact that formulation challenges still exist around stevia in terms of its bitter aftertaste, regardless of which market a company is targeting.
Discussing the integration of recently acquired Burgundy Botanical Extracts into the Naturex fold, the CEO said the sales side of that company has already been amalgamated into the wider group. And Dikansky expects Naturex to gain pre-acquisition earning levels mid-next year.
The group has extremely ambitious growth terms with the CEO flagging up Naturex’s intention of acquiring five to six companies in the next six months.